ImpediMed
IPD.AXImpediMed Limited Price (IPD.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
2,021,740,728
(12.2972)%Revenue and Profitability
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 2,311,399 | 2,991,953 | 3,639,000 | 3,887,000 | 2,945,000 | 2,733,000 | 3,521,000 | 4,844,000 | 5,791,000 | 5,766,000 | 3,318,000 | 4,155,999 | 5,741,000 | 8,409,000 | 10,566,000 | 11,344,000 | 10,319,000 |
| Net Income | 0 | -9,754,128 | -14,027,655 | -11,402,000 | -14,822,000 | -12,342,000 | -8,464,000 | -7,935,000 | -14,797,000 | -25,980,000 | -27,571,000 | -27,248,000 | -23,996,000 | -21,377,000 | -20,706,000 | -19,874,000 | -20,521,000 | -19,790,000 |
| FCF USD | 0 | -9,150,049 | -12,551,605 | -10,462,000 | -11,299,000 | -11,890,000 | -7,691,000 | -6,834,000 | -10,889,000 | -22,531,000 | -25,901,000 | -23,613,000 | -19,622,000 | -21,379,000 | -15,715,000 | -20,885,000 | -24,092,000 | -20,894,000 |
| OCF USD | 0 | -7,416,381 | -11,786,199 | -10,386,000 | -11,299,000 | -11,797,000 | -7,675,000 | -6,802,000 | -10,757,000 | -22,422,000 | -25,566,000 | -23,458,000 | -19,588,000 | -19,218,000 | -13,258,000 | -15,664,000 | -18,049,000 | -17,789,000 |
Financial Health - DEBT
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.01 | 0.00 | -0.06 | -0.04 |
| D/E | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.00 | 0.02 | 0.03 |
| CA/CL | 8.17 | 5.75 | 3.27 | 8.38 | 10.23 | 7.83 | 7.95 | 9.54 | 11.80 | 16.85 | 11.20 | 6.64 | 2.55 | 4.98 | 3.15 | 6.44 | 8.88 | 6.33 |
| TA/TL | 9.13 | 6.55 | 4.32 | 9.29 | 10.75 | 8.51 | 9.34 | 10.49 | 12.31 | 17.04 | 11.60 | 7.21 | 3.32 | 5.80 | 3.94 | 7.67 | 8.75 | 7.53 |
| Total Debt | 775,449 | 64,024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 871,000 | 474,000 | 170,000 | 1,447,000 | 1,143,000 |
Management Performance
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | - | -99.40% | -134.87% | -52.24% | -73.23% | -77.35% | -89.00% | -59.03% | -43.46% | -30.38% | -52.36% | -85.67% | -169.71% | -80.45% | -83.20% | -38.80% | -33.69% | -42.61% |
| ROE | 0.00% | -79.30% | -139.34% | -51.29% | -71.66% | -71.30% | -79.89% | -58.64% | -42.47% | -30.47% | -46.89% | -76.10% | -152.02% | -78.13% | -81.16% | -38.94% | -33.71% | -48.57% |
| ROA | 0.00% | -67.20% | -107.10% | -45.77% | -64.99% | -62.92% | -71.34% | -53.05% | -39.02% | -28.68% | -42.85% | -65.85% | -106.83% | -64.65% | -60.54% | -33.86% | -29.85% | -42.12% |
| NM % | - | -422.00% | -468.85% | -313.33% | -381.32% | -419.08% | -309.70% | -225.36% | -305.47% | -448.63% | -478.17% | -821.22% | -577.38% | -372.36% | -246.24% | -188.09% | -180.90% | -191.78% |
| FCF / R% | 0.00% | -395.87% | -419.51% | -287.50% | -290.69% | -403.74% | -281.41% | -194.09% | -224.79% | -389.07% | -449.20% | -711.66% | -472.14% | -372.39% | -186.88% | -197.66% | -212.38% | -202.48% |
| FCF / NI% | - | 93.81% | 89.48% | 91.76% | 76.23% | 96.34% | 90.87% | 86.12% | 73.59% | 86.72% | 93.94% | 86.27% | 81.34% | 100.01% | 75.90% | 105.09% | 117.40% | 105.58% |
| Operating Margin (OM) | - | -17.25 | -18.02 | -17.95 | -20.62 | -31.40 | -36.93 | -30.92 | -25.53 | -25.84 | -30.74 | -61.66 | -55.03 | -43.56 | -32.20 | -27.51 | -27.43 | -32.07 |
Per Share
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.00 | -0.13 | -0.15 | -0.09 | -0.09 | -0.07 | -0.05 | -0.04 | -0.06 | -0.08 | -0.07 | -0.07 | -0.06 | -0.04 | -0.02 | -0.01 | -0.01 | -0.01 |
| SPS | 0.00 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| OCPS | 0.00 | -0.10 | -0.12 | -0.08 | -0.07 | -0.07 | -0.04 | -0.03 | -0.04 | -0.07 | -0.07 | -0.06 | -0.05 | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 |
| FCPS | 0.00 | -0.13 | -0.13 | -0.09 | -0.07 | -0.07 | -0.04 | -0.03 | -0.04 | -0.07 | -0.07 | -0.06 | -0.05 | -0.04 | -0.01 | -0.01 | -0.01 | -0.01 |
| BVPS | 0.23 | 0.17 | 0.10 | 0.18 | 0.13 | 0.10 | 0.06 | 0.07 | 0.13 | 0.27 | 0.16 | 0.09 | 0.04 | 0.05 | 0.02 | 0.03 | 0.03 | 0.02 |
Per Share - CAGR
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.00 | -0.13 | -0.15 | -0.09 | -0.09 | -0.07 | -0.05 | -0.04 | -0.06 | -0.08 | -0.07 | -0.07 | -0.06 | -0.04 | -0.02 | -0.01 | -0.01 | -0.01 |
| CAGR-SPS | 0.00 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| CAGR-OCPS | 0.00 | -0.10 | -0.12 | -0.08 | -0.07 | -0.07 | -0.04 | -0.03 | -0.04 | -0.07 | -0.07 | -0.06 | -0.05 | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 |
| CAGR-FCPS | 0.00 | -0.13 | -0.13 | -0.09 | -0.07 | -0.07 | -0.04 | -0.03 | -0.04 | -0.07 | -0.07 | -0.06 | -0.05 | -0.04 | -0.01 | -0.01 | -0.01 | -0.01 |
| CAGR-BVPS | 0.23 | 0.17 | 0.10 | 0.18 | 0.13 | 0.10 | 0.06 | 0.07 | 0.13 | 0.27 | 0.16 | 0.09 | 0.04 | 0.05 | 0.02 | 0.03 | 0.03 | 0.02 |